chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Report 200032239-1 describes bilateral shoulder pain in a 40 year old male who received a hepatitis-B vaccine prophylaxis of hepatitis B.   The reporter denied allergies, medical history, and concomitant medications.  On 26-Oct-00, the vaccinee received his first deltoid double pediatric dose of a hepatitis b vaccine  On 27-Oct-00, he experienced pain in both shoulders and in his arms down to his elbows. No treatment was given.   As of 30-Oct-00, the events were improving.
Same day post vax, the child had broke out in small red rash on abdomen, back, and arms. On 3/21/00, the child was brought to office-rash on most of body and very large red raised areas especially at injection site.
vomiting, fever, tuesday noc 23FEB, sz, intra-cranial hemorrage, all morning 24FEB till thursday given phenobarbital;
I continued to have foot pain after the doctor added colchicine. Contrary to this medication, it could cause new flare ups. I had  recurrent foot pain almost every week, November through December, a 6 to 8  week period. My doctor took blood test and monitored it and I changed my diet to eliminate  all things that have high levels of purine. The test confirmed that it lowered the uric acid in my blood. The symptoms have resolved but it is still being watched and still taking medication for it and still watching diet. In early December I also had trouble with my left eye. I was having decreased vision happening intermittently.  The doctor said there was inflammation likely caused my gout. I had a short course steroid of eye drops that resolved the issue. You do understand that I am not saying these are connected to the vaccine. I am just reporting the adverse events that occurred following my vaccine. Note: 4 to 6 weeks prior to the Moderna Dose 3, I had a flu shot.
Patient came to pharmacy today at 1:45 pm with red arm you could see the injection mark from the shot then you could see the irritation from the shot to about her elbow. She went to the doctor who prescribed BENADRYL and triamcinolone cream. Patient stated it did not hurt just looks bad.
This spontaneous report as received from a nurse refers to an unknown number of patients. No further information regarding the patients was available. On an unknown date the patients were vaccinated with improperly stored ROTATEQ (lot #J010966, expiration date 20-MAR-2015 and lot # J010140 expiration 26-APR-2015). Strength, dose and route were not provided. ROTATEQ was exposed to a temperature between 46.5F and a highest of 48F for a total of 45 hours and 5 minutes from 10-APR-2014 to 02-MAY-2014: Out of range for 2 hours from 10-APR-2014 to 11-APR-2014; out of range for 10 hours and 15 minutes on 12-APR-2014; out of range for 12 hours and 25 minutes on 13-APR-2014; out of range for 1.5 hours on 14-APR-2014; out of range for 9.5 hours on 01-MAY-2014; out of range for 9 hours and 25 minutes on 02-MAY-2014. No adverse effects were reported.  Follow up information has been received from the registered nurse and reported that ROTATEQ stability cut off date was 02-MAY-2014. The registered nurse stated that anyone who was vaccinated with vaccine after these dates needed to be contacted for re-vaccination. The registered nurse refused to share patient identifiers on these patients, per Health Insurance Portability and Accountability Act (HIPPA).  HIPPA was reviewed with the nurse and she stated she would need to get that information from her supervisor. The phone call was transferred to her Supervisor.   The follow up information provided the primary reporter's occupation as a medical assistant. She reported that 3 unspecified patients were vaccinated with the improperly stored ROTATEQ. This case refers to 2 unspecified patients vaccinated with the third dose of ROTATEQ. There was one patient vaccinated with dose number 2 (case#1406USA00050). All patient received the vaccine on 02-MAY-2014. Lot # and expiration date for all patients vaccinated with ROTATEQ was J010966, 20-MAR-2015 (previously it was reported that also lot# J010140 with expiration date 26-APR-2015 was used).   Follow up was received from medical assistant regarding 6 months old (also reported as 8 months) female patient. On 02-MAY-2014 at 10:01 the patient was vaccinated orally with the third dose of ROTATEQ lot number J010966 expiration date 20-MAR-2015. Concomitant therapies included PREVNAR13, MRC-15, and PENTACEL. There were none adverse events reported.  This is one of several reports received from the same reporter. Additional information is not expected.
Patient was accidentally given more than one dose.  Medical provider and Pharmacy contacted. Resident has been and will continue to be monitored. There has been no adverse reaction.
It started 3 days after, while resting. She has high heart rate that felt like she was having an A Fib attack. She rested and tried to do calming exercises. The first night she tried to take pressure off her carotid artery. She did this for 2 days. The third day she was trying to eat dinner with a date. She had to leave her date and went home. These episodes are happening regularly. She called family and they told her to get checked. She has to wait on her doctor to get her in for an appointment. She has been resting and doing other tricks.
This is in follow-up to repor (s) previously submitted on 4/6/2007. Information has been received from a physician via a company representative concerning a "very nervous" 17 year old female who on approximately 26, Feb 2007 ("earlier this week") was vaccinated IM with a 0.5 mL dose of HPV rL1 6 11 16 18 VLP vaccine (yeast) (lot # not reported). On approximately 26, Feb 2007 ("after injection") the patient fainted. The patient sought unspecified medical attention and was reported as recovered (date not specified). Additional information has been requested. In follow-up it was reported by a registered nurse concerning a "very nervous", 17 year old, female, student, with allergy to codine and no illness at the time of vaccination, whose reported weight was 123 pounds who on 26-FEB-2007 was vaccinated intramuscularly (IM) into the left deltoid muscle with a 0.5 ml dose of GARDASIL (Lot # '02634'). It was reported that the patient had a dizzy feeling and then had a fainting episode. the patient did not fal, she was in a chair and her mother caught her. The nurse stepped out to get the patient water because the patient asked for some. The patient "wet pants" and the patient "came around with ammonia". Her pulse and blood pressure were okay. The patient was crying afterwards and scared. The patient was put on a bed "with head up to elevate her head". The tow physicians saw the patient in the office. The patient recovered and was released to her mother. On 27-FEB-2007, a phone call was placed to the patient's home. The patient's mother reported that the patient slept all afternoon and into the night. She ate dinner and had breakfast and went to school. The nurse told the patient's mother to call a or two before the next appointment to get a prescription for VALIUM, 20 mg and instructed to have the patient take the medication 20-30- minutes before the next appointment.
My arm was numb after the shot and i began to feel faint a few minutes after, my ears were ringing and thought i was going to pass out. I became very flushed and sweaty and my bangs were tingling
I had a stroke and its hard to talk and my left side is real weak. Getting physical therapy, occupational therapy and speech therapy now.
Pt received meningococcal vaccine/HPV #1 and FLUMIST 3/4/14. States on 3/5/14 she developed redness, warmth-to-touch and swelling from top of (L) deltoid, halfway down to elbow. Pt tried applying ice/hot salt water to site. (L) arm was still red and swollen on 3/7/14 but 3 1/2 x 3 1/2 inches. Advised to apply ice and take Ibuprofen - not to apply hot water.
Expired Product Used; This case was reported by a pharmacist via call center representative and described the occurrence of expired vaccine used in a 29-year-old male patient who received HAV (Havrix adult) (batch number 3A22R, expiry date 24th May 2022) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 27th May 2022, the patient received Havrix adult and Havrix Pre-Filled Syringe Device. On 27th May 2022, unknown after receiving Havrix adult and Havrix Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 27-May-2022 Reporter's Comments: The pharmacist reported they inadvertently administered an expired dose of Havrix  to a patient. The pharmacist inquired any side effects to look for. The reporter did not consent to follow-up. Additional Supportive Information: The patient was administrated with an expired dose of havrix which led to expired vaccine used.
This spontaneous report was received from a health professional via Pfizer (manufacturer control # 2016487324) and refers to a 67-year-old female patient. Her concurrent conditions included allergy to neuromuscular blockers, steroidal, noted on 24-MAY-2012 when the patient experienced vision loss and additionally intolerance to PERCOCET, that was noted on the same date, when she also experienced headache. On an unspecified date, the patient was vaccinated with PNEUMOVAX 23 (dose, route of administration, anatomical location, lot# and expiry date were not reported). Concomitant therapies were not reported. On 18-SEP-2015, the patient experienced PNEUMOVAX 23 intolerance. It was reported that she was "sicker than a dog" and suffered from nausea and vomiting. The outcome of the events was not reported. The events were considered to be related to PNEUMOVAX 23. Additional information has been requested.
Pain; Tiredness; Chills; Fast heart beat; Shortness of breath; This spontaneous case was reported by a consumer and describes the occurrence of TACHYCARDIA (Fast heart beat), DYSPNOEA (Shortness of breath), PAIN (Pain), FATIGUE (Tiredness) and CHILLS (Chills) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Palpitation, Tachycardia and Heart valve disorders (chest congestion due to leaky valve problem). Concomitant products included DIGOXIN, VERAPAMIL and PIROXICAM (MAXIDENE) for an unknown indication.   On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced TACHYCARDIA (Fast heart beat), DYSPNOEA (Shortness of breath) and CHILLS (Chills). On an unknown date, the patient experienced PAIN (Pain) and FATIGUE (Tiredness). On 13-Feb-2021, TACHYCARDIA (Fast heart beat), DYSPNOEA (Shortness of breath) and CHILLS (Chills) had resolved. At the time of the report, PAIN (Pain) and FATIGUE (Tiredness) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 28-Apr-2021: Additional information -Regulatory Authority. Concomitant medication and events(Fatigue, Pain) reported.
DIZZINESS; HEADACHE; A spontaneous report was received from a consumer concerning a  patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events dizziness, headache.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On unknown date, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: Denied) intramuscularly for prophylaxis of COVID-19 infection.   Dizziness, Headache.  Treatment details included unknown.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event(s), dizziness was unknown.The outcome of event(s), headache was unknown..
This spontaneous report was received from a nurse concerning an unspecified number of patient of an unknown age and gender. Medical history and concurrent conditions were not reported. On 21-JUL-2014, the patients were vaccinated with a dose of (Oka/Merck) VARIVAX (dose, route, lot number, expiration date, and route were not reported). Co-suspect and concomitant therapies were not reported. The nurse reported an unknown number of patients received improperly stored (Oka/Merck) VARIVAX on 21-JUL-2014. No adverse symptoms reported. Additional information has been requested.
About 8 minutes after receiving  the vaccine pt was feeling very dizzy, color drained from face and patient went limp. Very clammy and sweaty. Blood pressure was not obtainable. Patient was breathing but not responding to voice commands. EMS was called. While waiting patient started to come around but still very sweaty and mildly coherent. Once paramedics arrived vitals were rechecked and patients blood pressure was extremely low. She told paramedics she has a history of low blood pressure. Patient chose not to go with EMS and had her husband come pick her up and said if she wasnt feeling better she would go to hospital.
Twenty four hours after receiving the pneumonia vaccine my arm began to hurt, swell, skin around injection site turned very red and hot to the touch.  I became very sick, was in bed the full day except to go to the bathroom on the second day after receiving the vaccine.  A lump is also at the injection site.  I was told to use ice for 15 minutes, then off for 15 minutes.  I continued this for the entire weekend, every few hours.  On the following Monday I returned to the doctor, was put on antibiotics and benydryl.  The arm is still slightly red, and the lump at the injection site is still there.
Pt received MENACTRA, flu and GARDASIL on 9-23-14. Mom states she woke in the night at 10:00 pm on 9-23-14 with red dots on her trunk and woke in the middle of the night with body aches and felt hot to the touch. Felt "weak", dizzy with malaise. Wheezing (per pt) on Wed. night rx with VENTOLIN.
COVID+ 1/21/2023.  Vaccination Status - Moderna x2, Pfizer x1 + Pfizer BIVALENT Booster x1 Admission Date: 1/21/2023 Discharge Date: Jan 27, 2023   Active Hospital Problems   Diagnosis Date Noted POA ? COVID-19 01/21/2023 Yes ? Dysarthria 07/06/2019 Yes ? Mild vascular dementia without behavioral disturbance, psychotic disturbance, mood disturbance, or anxiety 03/21/2019 Yes ? History of stroke 01/01/2009 Yes  DETAILS OF HOSPITAL STAY:   PRESENTING PROBLEM: Slurred speech  Hypoxia  COVID-19 virus infection  COVID-19    HOSPITAL COURSE: 91 year-old male. history of vascular dementia, CVAs, HLD, and dysphagia (from CVAs) who is a long-term care patient.  presented with cough and confusion as well as slurred speech and nausea with retching. he was noted to be hypoxic, requiring 2-3 L nasal cannula. COVID test was positive. he was admitted, started on remdesivir and decadron. on admission patient noted to have increasing confusion which quickly improved to baseline mental status. CT head without acute deficits and evaluated by neurology without further neurological workup. symptoms improved and he was able to be weaned down to 1L. patient cleared for discharge, requiring 1L with his only complaint being an improving cough and some debility. patient's daughter disputed discharge primarily because she did not want the patient to go back to his previous facility as she had issues with the facility but also did not want him to go back to a COVID unit where she was concerned he might get sicker; it was re-iterated that from e medical standpoint the patient remained medically cleared and that his discharge plan was felt to be safe and sufficient. patient finished his course of remdesivir and was discharged on the remainder of his ten day course of decadron; daughter had mentioned during one of numerous calls to our CM that she was under the impression a patient had to stay inpatient for decadron, she was told this is not the case. patient's discharge was delayed because daughter disputed discharge, citing she did not want him to go back to that facility, patient was discharged 1/27. CONSULTS:   neurology (neuro)
pt c/o soreness, redness of affected arm; area felt warm to touch; pt applied cold compresses to area;
Fever; headache; Body aches; tiredness; This is a spontaneous report from non-contactable consumer, the patient. A non-pregnant elderly female patient of unspecified age received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA; Lot Number: ER2613), via an unspecified route of administration in the right arm on 25Mar2021 at 09:45 as a single dose for COVID-19 immunisation. Medical history included diabetes and COVID-19. Prior to the vaccination, the patient was diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. On 25Mar2021 at 17:00, the patient had experienced fever, headache, body aches and tiredness. The patient did not receive any treatment for the reported events. Adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events fever, headache, body aches and tiredness was unknown at the time of reporting.  No follow-up attempts are needed. No further information is expected.
Severe swelling, redness and itchiness at vaccination site 8 days after injection. Went away after 3-4 days.
This spontaneous report was received from a physician via a company representative and refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 02-JUN-2015, the patient was vaccinated with a dose of improperly stored VAQTA (10Pk 50U/1 mL) lot number K008984, expiration date of 21-OCT-2015 (route of administration was not reported), which was stored 2 times with the following lowest recorded temperatures: 34F (1.111 Celsius degrees) for 88 hours and 32 F (0 Celsius degrees) for 40 hours. No highest reported temperatures were reported. The type of storage was refrigerator. No concomitant therapies were reported. No adverse effects were reported. No product quality complaint (PQC) was involved. This is one of several cases from the same reporter. Additional information has been requested.
Dizziness, Diarrhea,  Feels weak and tired  Narrative:
Received TDAP in right arm 6/9 at roughly 06:30. Onset of chills and fever 6/10 at 04:30 AM. On 6/11 fever accompanied by headache. Fever reported to reach a high of maximum 107.7. Reaction site 12cm X 15 1/2cm. In addition, injection site red, swollen and mildly tender.
On 1/14/2020@approximately 8:15am--Patient came to clinic this morning with complaints of left arm "itching, red, hot to touch, and hard area with bumps". Patient received a varicella vaccine on 12/31/2019. And today, she reports symptoms started on 1/12/2020 with small, red bumps x2 on left arm, and itching where the vaccine was given. Patient reports itching became worse on Monday (1/13/2020) with area becoming "red, swollen and hard & feverish to touch". Patient applied ice pack and hydrocortisone topically for the itching. Also, patient reported taking aspirin on 1/7/2020 with these symptoms starting on 1/12/2020.
Initial unsolicited report received from a nurse on 18 August 2016. This case involves a 17-years-old male patient who was vaccinated with a dose of MENACTRA (batch number U5416AA, expiry date, dose, route of administration were not reported) in left arm on 11 August 2016. Illness at time of vaccination reported as denies and pre-existing physician diagnosed allergies, birth defects, medical conditions were not reported. Concomitant medications were not reported. On 17 August 2016, six days following the vaccination the patient experienced, chest pain, n/v (nausea and vomiting), increase in body temperature as 102.8, general muscle aches, sore throat. It was reported that patient visited to doctor. Lab data and corrective treatment was not reported. The outcome of events reported as unknown. List of documents held by sender: none.
With the first vaccine, I had fatigue and slept a couple hours, and the second vaccine I developed diarrhea and I couldn't sleep as well which lasted for three to four days. After the booster I have a headache, I took a Tylenol at 9 am and again 12 pm. I sat most of the day, and it felt like my legs were going to buckle underneath me. I found myself really thirsty and I couldn't stop drinking water. I felt very dehydrated. Every movement I made bothered me. After 24 hours my symptoms did go away.
Sore arm near injection site and throughout arm; minor numbness in elbow and fingers; Sore arm near injection site and throughout arm; This is a spontaneous report from a contactable consumer reported for himself. A 28-years-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number=EL3247), via an unspecified route of administration in left arm on 25Jan2021 14:15 at first single dose for covid-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. No allergies to medications, food, or other products. No other medical history. No other medications the patient received within 2 weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced sore arm near injection site and throughout arm including minor numbness in elbow and fingers. Adverse event start date: 25Jan2021 04:30 PM. No treatment was received for the adverse event. Since the vaccination, the patient has not been tested for COVID-19. Outcome of the events was not recovered.
On July 15, 2022 I had a pain and burning sensation in the right hand within a few hours I had red spots appear and the burning and pain was more intense.  I went to the doctor two days later and she stated it looked like shingles and prescribed me some pain medication.  It did stay generalized to my hand.  It took about three and a half weeks before it went away.
Swollen lymph nodes; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (Swollen lymph nodes) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (Swollen lymph nodes). At the time of the report, LYMPHADENOPATHY (Swollen lymph nodes) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Reporter/Patient was irritated with being on hold for a long time and was not cooperative in answering questions though did provide a phone number.  Treatment of events was not reported. Concomitant medication use was not provided by the reporter.
Left arm swelling, redness, warmth from elbow to shoulder.  Mild lethargy.
UNKNOWN PRIMARY CARE PROVIDER. ONLY INTERACTION WITH PATIENT WAS COVID-19 SWAB.